|
1
|
Kumar V, Abbas AK, Fausto N and Mitchell
RN: Robbins Basic Pathology. 8th edition. Saunders Elsevier;
Philadelphia, PA: pp. 516–522. 2007
|
|
2
|
Konstantinos A: Testing for tuberculosis.
Aust Prescr. 33:12–18. 2010.
|
|
3
|
Szatmari I and Nagy L: Nuclear receptor
signalling in dendritic cells connects lipids, the genome and
immune function. EMBO J. 27:2353–2362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Szanto A and Nagy L: Retinoids potentiate
peroxisome proliferator-activated receptor gamma action in
differentiation, gene expression, and lipid metabolic processes in
developing myeloid cells. Mol Pharmacol. 67:1935–1943. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Szatmari I, Töröcsik D, Agostini M, et al:
PPARgamma regulates the function of human dendritic cells primarily
by altering lipid metabolism. Blood. 110:3271–3280. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Braissant O, Foufelle F, Scotto C, Dauça M
and Wahli W: Differential expression of peroxisome
proliferator-activated receptors (PPARs): tissue distribution of
PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology.
137:354–366. 1996.PubMed/NCBI
|
|
7
|
Rigamonti E, Fontaine C, Lefebvre B, et
al: Induction of CXCR2 receptor by peroxisome
proliferator-activated receptor gamma in human macrophages.
Arterioscler Thromb Vasc Biol. 28:932–939. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Almeida PE, Silva AR, Maya-Monteiro CM, et
al: Mycobacterium bovis bacillus Calmette-Guérin infection induces
TLR2-dependent peroxisome proliferator-activated receptor gamma
expression and activation: functions in inflammation, lipid
metabolism, and pathogenesis. J Immunol. 183:1337–1345. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bruns H, Meinken C, Schauenberg P, et al:
Anti-TNF immunotherapy reduces CD8+ T cell-mediated
antimicrobial activity against Mycobacterium tuberculosis in
humans. J Clin Invest. 119:1167–1177. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mohan VP, Scanga CA, Yu K, et al: Effects
of tumor necrosis factor alpha on host immune response in chronic
persistent tuberculosis: possible role for limiting pathology.
Infect Immun. 69:1847–1855. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dlugovitzky D, Bay ML, Rateni L, et al:
Influence of disease severity on nitrite and cytokine production by
peripheral blood mononuclear cells (PBMC) from patients with
pulmonary tuberculosis (TB). Clin Exp Immunol. 122:343–349. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Al-Attiyah R, El-Shazly A and Mustafa AS:
Comparative analysis of spontaneous and mycobacterial
antigen-induced secretion of Th1, Th2 and pro-inflammatory
cytokines by peripheral blood mononuclear cells of tuberculosis
patients. Scand J Immunol. 75:623–632. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jones SA, Scheller J and Rose-John S:
Therapeutic strategies for the clinical blockade of IL-6/gp130
signaling. J Clin Invest. 121:3375–3383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Silva LC, Ortigosa LC and Benard G:
Anti-TNF-α agents in the treatment of immune-mediated inflammatory
diseases: mechanisms of action and pitfalls. Immunotherapy.
2:817–833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roach SK and Schorey JS: Differential
regulation of the mitogen-activated protein kinases by pathogenic
and nonpathogenic mycobacteria. Infect Immun. 70:3040–3052. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Senthil KA, Bansal K, Holla S, Verma-Kumar
S, Sharma P and Balaji KN: ESAT-6 induced COX-2 expression involves
coordinated interplay between PI3K and MAPK signaling. Mol Immunol.
49:655–663. 2012. View Article : Google Scholar
|
|
17
|
Lee SH, Kim DW, Back SS, et al: Transduced
Tat-Annexin protein suppresses inflammation-associated gene
expression in lipopolysaccharide (LPS)-stimulated Raw 264.7 cells.
BMB Rep. 44:484–489. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang W and Liu HT: MAPK signal pathways
in the regulation of cell proliferation in mammalian cells. Cell
Res. 12:9–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Surewicz K, Aung H, Kanost RA, Jones L,
Hejal R and Toossi Z: The differential interaction of p38 MAP
kinase and tumor necrosis factor-alpha in human alveolar
macrophages and monocytes induced by Mycobacterium tuberculois.
Cell Immunol. 228:34–41. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Andersson M, Lutay N, Hallgren O,
Westergren-Thorsson G, Svensson M and Godaly G: Mycobacterium bovis
bacilli Calmette-Guerin regulates leukocyte recruitment by
modulating alveolar inflammatory responses. Innate Immun.
18:531–540. 2012. View Article : Google Scholar
|
|
21
|
Schlesinger LS, Bellinger-Kawahara CG,
Payne NR and Horwitz MA: Phagocytosis of Mycobacterium tuberculosis
is mediated by human monocyte complement receptors and complement
component C3. J Immunol. 144:2771–2780. 1990.PubMed/NCBI
|
|
22
|
Sánchez A, Espinosa P, García T and
Mancilla R: The 19 kDa Mycobacterium tuberculosis lipoprotein
(LpqH) induces macrophage apoptosis through extrinsic and intrinsic
pathways: a role for the mitochondrial apoptosis-inducing factor.
Clin Dev Immunol. 2012:9505032012. View Article : Google Scholar
|
|
23
|
Brightbill HD, Libraty DH, Krutzik SR, et
al: Host defense mechanisms triggered by microbial lipoproteins
through toll-like receptors. Science. 285:732–736. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Straus DS and Glass CK: Anti-inflammatory
actions of PPAR ligands: new insights on cellular and molecular
mechanisms. Trends Immunol. 28:551–558. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moraes LA, Piqueras L and Bishop-Bailey D:
Peroxisome proliferator-activated receptors and inflammation.
Pharmacol Ther. 110:371–385. 2006. View Article : Google Scholar
|
|
26
|
Mei CL, He P, Cheng B, Liu W, Wang YF and
Wan JJ: Chlamydia pneumoniae induces macrophage-derived foam cell
formation via PPAR alpha and PPAR gamma-dependent pathways. Cell
Biol Int. 33:301–308. 2009. View Article : Google Scholar
|
|
27
|
Liu YL, Lu J, Shi J, et al: Increased
expression of the peroxisome proliferator-activated receptor gamma
in the immune system of weaned pigs after Escherichia coli
lipopolysaccharide injection. Vet Immunol Immunopathol. 124:82–92.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pascual G, Fong AL, Ogawa S, et al: A
SUMOylation-dependent pathway mediates transrepression of
inflammatory response genes by PPAR-gamma. Nature. 437:759–763.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
de Assis EF, Silva AR, Caiado LFC, et al:
Synergism between platelet-activating factor-like phospholipids and
peroxisome proliferator-activated receptor gamma agonists generated
during low density lipoprotein oxidation that induces lipid body
formation in leukocytes. J Immunol. 171:2090–2098. 2003. View Article : Google Scholar : PubMed/NCBI
|
